News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
485,019 Results
Type
Article (26606)
Company Profile (171)
Press Release (458242)
Section
Business (135291)
Career Advice (466)
Deals (22961)
Drug Delivery (41)
Drug Development (79795)
Employer Resources (45)
FDA (13138)
Job Trends (9748)
News (249816)
Policy (20579)
Tag
Academia (1859)
Alliances (38143)
Alzheimer's disease (1279)
Approvals (13087)
Artificial intelligence (166)
Bankruptcy (152)
Best Places to Work (8412)
Biotechnology (132)
Breast cancer (204)
Cancer (1522)
Cardiovascular disease (113)
Career advice (409)
CAR-T (110)
Cell therapy (299)
Clinical research (65248)
Collaboration (528)
Compensation (248)
COVID-19 (2092)
C-suite (122)
Data (1480)
Diabetes (159)
Diagnostics (5285)
Earnings (49845)
Events (75368)
Executive appointments (429)
FDA (13850)
Funding (464)
Gene therapy (194)
GLP-1 (478)
Government (2441)
Healthcare (14090)
Infectious disease (2168)
Inflammatory bowel disease (117)
IPO (11486)
Job creations (1705)
Job search strategy (374)
Layoffs (269)
Legal (3072)
Lung cancer (230)
Lymphoma (98)
Manufacturing (151)
Medical device (9605)
Medtech (9607)
Mergers & acquisitions (11791)
Metabolic disorders (393)
Neuroscience (1637)
NextGen: Class of 2025 (4031)
Non-profit (2514)
Northern California (1746)
Obesity (200)
Opinion (132)
Parkinson's disease (107)
Patents (93)
People (39818)
Phase I (20935)
Phase II (29054)
Phase III (21100)
Pipeline (585)
Postmarket research (2117)
Preclinical (7628)
Radiopharmaceuticals (243)
Rare diseases (275)
Real estate (3375)
Regulatory (16416)
Research institute (1950)
Southern California (1504)
Startups (2640)
United States (14233)
Vaccines (413)
Weight loss (115)
Date
Today (64)
Last 7 days (495)
Last 30 days (1978)
Last 365 days (30011)
2025 (1911)
2024 (30364)
2023 (34421)
2022 (43476)
2021 (45640)
2020 (42137)
2019 (32467)
2018 (24413)
2017 (25401)
2016 (23366)
2015 (27360)
2014 (20085)
2013 (15620)
2012 (16389)
2011 (16946)
2010 (15954)
Location
Africa (414)
Arizona (112)
Asia (35851)
Australia (6047)
California (3918)
Canada (1251)
China (358)
Colorado (166)
Connecticut (179)
Europe (68181)
Florida (491)
Georgia (125)
Illinois (260)
Indiana (183)
Japan (94)
Maryland (512)
Massachusetts (2881)
Michigan (118)
Minnesota (202)
New Jersey (1016)
New York (1059)
North Carolina (701)
Northern California (1746)
Ohio (113)
Pennsylvania (841)
South America (553)
Southern California (1504)
Texas (570)
Utah (98)
Washington State (373)
485,019 Results for "clinical genomics pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
BioCapital
Eilean Therapeutics Joins The Leukemia & Lymphoma Society’s Groundbreaking Beat AML® Master Clinical Trial
Eilean Therapeutics AU Pty Ltd has joined The Leukemia & Lymphoma Society in the groundbreaking collaborative Beat AML® Master Clinical Trial.
June 11, 2024
·
4 min read
Press Releases
Ecotone Achieves Breakthrough in Human Genome Understanding with Novel AI Technology
AI-Powered Genomic Mapping Could Revolutionize Treatment of Rare Genetic Diseases
January 16, 2025
·
1 min read
Press Releases
Hanx Biopharmaceuticals, Ltd. Announces First Patient Dosing in First-in-Human Phase 1 Clinical Trial of HX044
January 2, 2025
·
2 min read
Business
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision
Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced the appointment of Mark W. Womack as a Director of the Board.
March 5, 2024
·
3 min read
CARTHERICS GRANTED EUROPEAN PATENT FOR MULTIPLE DEVELOPMENT CANDIDATES
Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer
May 23, 2024
·
2 min read
Press Releases
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
December 2, 2024
·
6 min read
Press Releases
Cerebras Systems and Mayo Clinic Unveil Best in Class Genomic Foundation Model
January 14, 2025
·
4 min read
CARTHERICS SECURES AUSTRALIAN PATENT FOR INNOVATIVE CANCER CELL THERAPY
Melbourne, Australia, 12 June 2024 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce...
June 12, 2024
·
2 min read
BioForest
Independent Studies Presented at ESCMID Global Demonstrate the Clinical Utility of SeptiCyte® RAPID in Patients Suspected of Sepsis, Including in Polytrauma Patients
Immunexpress, Pty Ltd. today announced the presentation of two posters evaluating SeptiCyte® RAPID at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) 2024, to take place from April 27 – 30 in Barcelona, Spain.
April 17, 2024
·
5 min read
1 of 48,502
Next
